Sawsan Rashdan, MD

Sawsan Rashdan, MD, is an assistant professor in the Department of Internal Medicine at UT Southwestern Medical Center, and a member of its Division of Hematology and Oncology.

Articles by Sawsan Rashdan, MD

Rashdan Explores the Safety/Efficacy of Osimertinib and SABR in EGFR+ NSCLC

BySawsan Rashdan, MD

June 11th 2024

Sawsan Rashdan, MD, discusses the background, findings, and next steps of a phase 2 study evaluating treatment with osimertinib and consolidative SABR for the treatment of EGFR-mutated NSCLC.

Sawsan Rashdan, MD

Articles by Sawsan Rashdan, MD

Rashdan Explores the Safety/Efficacy of Osimertinib and SABR in EGFR+ NSCLC

Latest Updated Articles

Trending on Targeted Oncology - Immunotherapy, Biomarkers, and Cancer Pathways

FDA Grants Traditional Approval to Pirtobrutinib in CLL/SLL

Durable Responses With Novel Cell Therapy TARA-002 in BCG-Naive NMIBC

JANX007 Shows Promising Efficacy, Safety in Phase 1 Trial Update

LP-184 Demonstrates Favorable Efficacy and Safety in Advanced Solid Tumors

Sac-TMT Demonstrates Antitumor Activity, Safety in Urothelial Carcinoma